Spots Global Cancer Trial Database for Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients
Official Title: Quantification of Therapy Effects After Microsurgery, Percutaneous Irradiation and Chemotherapy by FET-PET Analysis
Study ID: NCT01089868
Conditions
Interventions
Study Description
Brief Summary: The aim of this study is to establish FET-PET as an additional therapy assessment parameter in patients diagnosed with a glioblastoma multiforme receiving radiochemotherapy and adjuvant chemotherapy after previous resection or biopsy.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Department of Stereotactic Neurosurgery, Freiburg, Baden Wuertemberg, Germany
University Hospital Munich, Department of Neurosurgery, Munich, Bavaria, Germany
University Hospital Bonn, Department of Neurosurgery, Bonn, North Rhine-Westphalia, Germany
Contact Details
Name: Joerg C. Tonn, Prof. Dr.
Affiliation: Department of Neurosurgery, LMU, Munich
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
